- Trials with a EudraCT protocol (753)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
753 result(s) found for: Breast surgery.
Displaying page 1 of 38.
EudraCT Number: 2007-007257-31 | Sponsor Protocol Number: GIC/468 | Start Date*: 2008-11-07 | |||||||||||
Sponsor Name:IPOLFG | |||||||||||||
Full Title: Open-label, single arm, phase II study for evaluation of complete response rate at surgery after NEOadjuvant treatment with SUnitinib and docetaxel in patients with newly diagnosed large operable o... | |||||||||||||
Medical condition: large operable and locally advanced breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: PT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000510-59 | Sponsor Protocol Number: 01012014 | Start Date*: 2014-08-11 | |||||||||||
Sponsor Name:Dept of Plastic Surgery, Breast Surgery & Burns | |||||||||||||
Full Title: Fat transplantation enriched with ex vivo expanded adipose-derived autologous mesenchymal stem cells in reconstruction of the breast. | |||||||||||||
Medical condition: The study will include participants with breast hypoplasia (International Classification of Diseases-10: DQ 838A). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004878-26 | Sponsor Protocol Number: 26842468452 | Start Date*: 2013-02-07 |
Sponsor Name:Karolinska University Hospital Solna | ||
Full Title: Antibiotic prophylaxis in patients undergoing primary or secondary breast reconstruction with implants, a randomized parallel two armed prospective clinical trial. | ||
Medical condition: The incidence of postoperative infections in patients with breast cancer or a history of breast cancer, after elective surgery with primary or secondary first-time breast reconstruction with implan... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Prohibited by CA) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001526-27 | Sponsor Protocol Number: STH14707 | Start Date*: 2007-06-19 | |||||||||||
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | |||||||||||||
Full Title: ANZAC: A Randomised Phase II Feasibility Study Investigating The Biological Effects of the Addition of Zoledronic Acid To Neoadjuvant Comnination Chemotherapy On Invasive Breast Cancer | |||||||||||||
Medical condition: Breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004194-16 | Sponsor Protocol Number: IRFMN-BRC-6591 | Start Date*: 2015-01-19 | |||||||||||
Sponsor Name:IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI | |||||||||||||
Full Title: A multicenter, single-arm, phase II study to evaluate the activity of pre-operative zoledronate in triple negative breast cancer patients, according to p53 level | |||||||||||||
Medical condition: Newly diagnosed, untreated, operable triple negative breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000698-57 | Sponsor Protocol Number: MDV3100-11 | Start Date*: 2013-09-01 | |||||||||||
Sponsor Name:Medivation, Inc. | |||||||||||||
Full Title: A Phase 2, Single-Arm, Open-Label, Multicenter Study of the Clinical Activity and Safety of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple-Negative Breast Cancer | |||||||||||||
Medical condition: Breast Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BE (Completed) IT (Completed) IE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018862-22 | Sponsor Protocol Number: MammaMRI-PreBiopsy | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Kliniken Essen-Mitte | |||||||||||||
Full Title: Exploratory study to evaluate different MRI-contrast-agent-application-schemes using Gadovist to optimize contrast enhancement for longer lasting breast examination | |||||||||||||
Medical condition: Patients with recent diagnosis of breast cancer, histologically proven. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003559-39 | Sponsor Protocol Number: ICO-A-2018-10 | Start Date*: 2018-12-11 | |||||||||||
Sponsor Name:INSTITUT DE CANCEROLOGIE DE L'OUEST | |||||||||||||
Full Title: multicentric Study , open, randomized, comparing the topical treatment by patch of capsaïcine with 8 % ( Qutenza) to the oral prégabaline treatment in the early treatment of the neuropathic pains a... | |||||||||||||
Medical condition: men and /or women older than 18 years with breast cancer for which a surgical operation was realized. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000934-38 | Sponsor Protocol Number: CP-BR-1-2007 | Start Date*: 2007-10-30 | |||||||||||
Sponsor Name:Generex Biotechnology Corporation | |||||||||||||
Full Title: Prospective, Randomized, Single-Blinded, Multi-Center Phase II Trial of the HER2/neu Peptide GP2 + GM-CSF Vaccine versus GM-CSF Alone in HLA-A2+ OR the Modified HER2/neu Peptide AE37 + GM-CSF Vacci... | |||||||||||||
Medical condition: Disease-free, conventionally treated node-positive and high-risk node-negative breast cancer patients who are at significant risk for recurrence. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006236-22 | Sponsor Protocol Number: MET/TEST1106 | Start Date*: 2007-01-31 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA O.I.R.M. - S. ANNA | |||||||||||||
Full Title: Use of Metformin to reduce serum level of Testosterone and improve the metabolic picture in women treated for breast cancer | |||||||||||||
Medical condition: Menopausal women on treatment for BC, with higher risk of recurrence due to augmented level of T | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005863-32 | Sponsor Protocol Number: MAST1 | Start Date*: 2008-11-27 | |||||||||||
Sponsor Name:Department of Oncology | |||||||||||||
Full Title: A Phase II Study of Neo-Adjuvant Statin Therapy in Postmenopausal Primary Breast Cancer - a Window-of Opportunity Study | |||||||||||||
Medical condition: Postmenopausal women with primary invasive breast cancer. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005592-17 | Sponsor Protocol Number: P05059 | Start Date*: 2006-12-14 | |||||||||||
Sponsor Name:Schering-Plough AB Sweden | |||||||||||||
Full Title: Caelyx® in Breast Cancer in the Elderly Pegylated Liposomal Doxorubicin (Caelyx®) as monotherapy in elderly patients with locally advanced and/or metastatic breast cancer | |||||||||||||
Medical condition: Locally advanced and/or metastatic breast cancer, not amenable to surgery. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004326-25 | Sponsor Protocol Number: Shother 2007-004326-25 | Start Date*: 2007-11-15 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA | |||||||||||||
Full Title: SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN BREAST CANCER PATIENTS WITH HER2 POSITIVE DISEASE | |||||||||||||
Medical condition: carcinoma mammario con iperespressione di Her 2 o amplificazione dei geni codificanti per il recettore stesso. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018795-24 | Sponsor Protocol Number: APREC S-2010-01 | Start Date*: 2010-06-01 | |||||||||||
Sponsor Name:Alliance pour la recherche en cancérologie | |||||||||||||
Full Title: Evaluation of the effect of pasireotide LAR administration in the lymphocele prevention after axillary node dissection for breast cancer | |||||||||||||
Medical condition: BREAST CANCER | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000520-14 | Sponsor Protocol Number: IEO S291/106 | Start Date*: 2006-10-26 | |||||||||||
Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA | |||||||||||||
Full Title: A PHASE II STUDY OF GW572016 LAPATINIBTM ON CELL PROLIFERATION IN HER-2/neu ErbB2 POSITIVE BREAST CANCER BEFORE SURGERY. | |||||||||||||
Medical condition: Primary breast cancer T1-3 N0-1 M0 Histologically-confirmed HER 2 positive | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003220-52 | Sponsor Protocol Number: CC-486-BRSTM-001 | Start Date*: 2015-03-21 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Celgene Corporation | ||||||||||||||||||||||||||||||||||||||
Full Title: A Phase 2, Randomized, Open-Label, Two-arm Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With Fulvestrant in Postmenopausal... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Postmenopausal female subjects with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer, who have progressed on an aromatase inhibi... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Completed) ES (Completed) DE (Completed) FR (Completed) IT (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-003530-13 | Sponsor Protocol Number: 18072011 | Start Date*: 2011-12-20 | |||||||||||
Sponsor Name:Brighton & Sussex University Hospitals NHS Trust | |||||||||||||
Full Title: Randomised phase II window study of short-term preoperative treatment with the PI3K inhibitor GDC-0941 plus Anastrozole versus Anastrozole alone in patients with ER-positive primary breast cancer | |||||||||||||
Medical condition: Primary breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003932-32 | Sponsor Protocol Number: ESTEeM 112984 U106/7672 | Start Date*: 2006-12-14 | |||||||||||
Sponsor Name:The University of Leeds [...] | |||||||||||||
Full Title: Endocrine +/- Surgical Therapy for Elderly women with Mammary cancer | |||||||||||||
Medical condition: Women 75 years or over with invasive, operable, moderate or strongly ER+ve, primary breast cancer. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002061-12 | Sponsor Protocol Number: SBG2004-1/ABCSG25/GBG53 | Start Date*: 2007-08-17 | |||||||||||
Sponsor Name:ABCSG (Austrian Breast & Colorectal Cancer Study Group) | |||||||||||||
Full Title: PANTHER (The SBG 2004-1/ABCSG 25/GBG53 Protocol) - a randomised phase III study: Comparing two weekly and tailored epirubicin + cyclophosphamide followed by two weekly tailored docetaxel (dtEC->dtT... | |||||||||||||
Medical condition: lymph node positive breast cancer patients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) FI (Prematurely Ended) DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-005186-31 | Sponsor Protocol Number: 01062017 | Start Date*: 2018-06-06 | ||||||||||||||||
Sponsor Name:Department of Plastic Surgery, Breast and Burns Treatment | ||||||||||||||||||
Full Title: Fat Grafting with Ex-Vivo Expanded Adipose-Derived Stem Cells for Breast Reconstruction Following Mastectomy | ||||||||||||||||||
Medical condition: This study will include patients with genetic predisposition to development of breast cancer, who are offered prophylactic bilateral skin-sparring mastectomy. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
